Effect of TLR2 on the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancer

Abstract Background Colitis-associated cancer (CAC) is a complication of inflammatory bowel disease (IBD) with a poor prognosis because it is often diagnosed in advanced stages with local progression or metastasis. Compared with the more common polyp-induced sporadic colorectal cancer (sCRC), CAC ha...

Full description

Bibliographic Details
Main Authors: Shuang Meng, Yingjie Li, Xiaozhen Zang, Zheng Jiang, Huahan Ning, Jing Li
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Cancer Cell International
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12935-020-01184-0
_version_ 1819095836529786880
author Shuang Meng
Yingjie Li
Xiaozhen Zang
Zheng Jiang
Huahan Ning
Jing Li
author_facet Shuang Meng
Yingjie Li
Xiaozhen Zang
Zheng Jiang
Huahan Ning
Jing Li
author_sort Shuang Meng
collection DOAJ
description Abstract Background Colitis-associated cancer (CAC) is a complication of inflammatory bowel disease (IBD) with a poor prognosis because it is often diagnosed in advanced stages with local progression or metastasis. Compared with the more common polyp-induced sporadic colorectal cancer (sCRC), CAC has different molecular mechanisms. Toll-like receptor 2 (TLR2) expression is not limited to cells related to inflammation and immune function. High levels of TLR2 expression in tumor tissues of colorectal cancer (CRC) patients have been reported. This report is to investigate the effects of knockout and knockdown of the TLR2 gene on the proliferation of CAC and sCRC. Methods Twelve C57BL/6 J wild-type mice (WT) and 12 TLR2 knockout mice (TLR2-/-) were used to rapidly establish a colitis-associated cancer (CAC) model via the 1,2-dimethylhydrazine-dextran sodium sulfate (DMH-DSS) method and were divided into the normal WT control group (NC), TLR2 knockout control group (KC), normal wild-type tumor modeling group (NT), and TLR2 knockout tumor modeling group (KT), with 6 mice in each group. The general performance of the mice during modeling, the gross changes of the colon and the rectum, and the pathological score of HE staining were used to observe tumor growth. The expression of TLR2 was detected by immunohistochemistry, and tumor proliferation was detected by Ki67 labeling. Lentivirus carrying TLR2-RNAi was used to stably infect colorectal cancer cells (HCT116 and HT29) to knock down TLR2 gene expression. The experimental groups included the uninfected control group, negative control group, and gene knockdown group. After infection, the expression of TLR2 protein was detected by Western blot, and cell proliferation and the cell cycle were detected by the CCK-8 method and fluorescence-activated cell sorting. Western blot was used to detect the expression levels of p- NF-κβ, cyclin D1 and cyclin D3 protein in each group of cells. Results TLR2 knockout in the CAC model resulted in greater changes in body weight and more severe diarrhea and colorectal hemorrhage. However, knocking out the TLR2 gene reduced the shortening of colorectal length, the number of tumors, and the total tumor volume and inhibited the growth of CAC. Knocking out the TLR2 gene also reduced the pathological score and tumor severity. TLR2 was localized in the cell membrane of the colorectal epithelium of the NC group and of the colorectal tumors of the NT group and was highly expressed in the NT group, while antigen Ki67 was localized in the nucleus of the colorectal tumor cells of the NT group and the KT group, and its expression was reduced in the KT group. In an in vitro sporadic colorectal cancer cell experiment, TLR2 protein in the TLR2 knockdown group was significantly downregulated, and TLR2 knockdown significantly inhibited the proliferation of HCT116 and HT29 colorectal cancer cells, resulting in G1 phase arrest. The expression levels of p-NF-κβ, cyclin D1 and cyclin D3 proteins in TLR2 gene knockdown group cells were significantly reduced. Conclusion Knockout and knockdown of TLR2 can inhibit the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancer.
first_indexed 2024-12-21T23:49:38Z
format Article
id doaj.art-08acc484f7b94fcd90766530ee0e4c86
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-12-21T23:49:38Z
publishDate 2020-03-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-08acc484f7b94fcd90766530ee0e4c862022-12-21T18:45:58ZengBMCCancer Cell International1475-28672020-03-0120111310.1186/s12935-020-01184-0Effect of TLR2 on the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancerShuang Meng0Yingjie Li1Xiaozhen Zang2Zheng Jiang3Huahan Ning4Jing Li5Department of Gastroenterology, The First Affiliated Hospital of Jinzhou Medical UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Jinzhou Medical UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Jinzhou Medical UniversityJinzhou No. 2 HospitalDepartment of Gastroenterology, The First Affiliated Hospital of Jinzhou Medical UniversityDepartment of Gastroenterology, The First Affiliated Hospital of Jinzhou Medical UniversityAbstract Background Colitis-associated cancer (CAC) is a complication of inflammatory bowel disease (IBD) with a poor prognosis because it is often diagnosed in advanced stages with local progression or metastasis. Compared with the more common polyp-induced sporadic colorectal cancer (sCRC), CAC has different molecular mechanisms. Toll-like receptor 2 (TLR2) expression is not limited to cells related to inflammation and immune function. High levels of TLR2 expression in tumor tissues of colorectal cancer (CRC) patients have been reported. This report is to investigate the effects of knockout and knockdown of the TLR2 gene on the proliferation of CAC and sCRC. Methods Twelve C57BL/6 J wild-type mice (WT) and 12 TLR2 knockout mice (TLR2-/-) were used to rapidly establish a colitis-associated cancer (CAC) model via the 1,2-dimethylhydrazine-dextran sodium sulfate (DMH-DSS) method and were divided into the normal WT control group (NC), TLR2 knockout control group (KC), normal wild-type tumor modeling group (NT), and TLR2 knockout tumor modeling group (KT), with 6 mice in each group. The general performance of the mice during modeling, the gross changes of the colon and the rectum, and the pathological score of HE staining were used to observe tumor growth. The expression of TLR2 was detected by immunohistochemistry, and tumor proliferation was detected by Ki67 labeling. Lentivirus carrying TLR2-RNAi was used to stably infect colorectal cancer cells (HCT116 and HT29) to knock down TLR2 gene expression. The experimental groups included the uninfected control group, negative control group, and gene knockdown group. After infection, the expression of TLR2 protein was detected by Western blot, and cell proliferation and the cell cycle were detected by the CCK-8 method and fluorescence-activated cell sorting. Western blot was used to detect the expression levels of p- NF-κβ, cyclin D1 and cyclin D3 protein in each group of cells. Results TLR2 knockout in the CAC model resulted in greater changes in body weight and more severe diarrhea and colorectal hemorrhage. However, knocking out the TLR2 gene reduced the shortening of colorectal length, the number of tumors, and the total tumor volume and inhibited the growth of CAC. Knocking out the TLR2 gene also reduced the pathological score and tumor severity. TLR2 was localized in the cell membrane of the colorectal epithelium of the NC group and of the colorectal tumors of the NT group and was highly expressed in the NT group, while antigen Ki67 was localized in the nucleus of the colorectal tumor cells of the NT group and the KT group, and its expression was reduced in the KT group. In an in vitro sporadic colorectal cancer cell experiment, TLR2 protein in the TLR2 knockdown group was significantly downregulated, and TLR2 knockdown significantly inhibited the proliferation of HCT116 and HT29 colorectal cancer cells, resulting in G1 phase arrest. The expression levels of p-NF-κβ, cyclin D1 and cyclin D3 proteins in TLR2 gene knockdown group cells were significantly reduced. Conclusion Knockout and knockdown of TLR2 can inhibit the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancer.http://link.springer.com/article/10.1186/s12935-020-01184-0Inflammation-related colorectal cancerSporadic colorectal cancerToll-like receptor 2Cell proliferation
spellingShingle Shuang Meng
Yingjie Li
Xiaozhen Zang
Zheng Jiang
Huahan Ning
Jing Li
Effect of TLR2 on the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancer
Cancer Cell International
Inflammation-related colorectal cancer
Sporadic colorectal cancer
Toll-like receptor 2
Cell proliferation
title Effect of TLR2 on the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancer
title_full Effect of TLR2 on the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancer
title_fullStr Effect of TLR2 on the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancer
title_full_unstemmed Effect of TLR2 on the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancer
title_short Effect of TLR2 on the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancer
title_sort effect of tlr2 on the proliferation of inflammation related colorectal cancer and sporadic colorectal cancer
topic Inflammation-related colorectal cancer
Sporadic colorectal cancer
Toll-like receptor 2
Cell proliferation
url http://link.springer.com/article/10.1186/s12935-020-01184-0
work_keys_str_mv AT shuangmeng effectoftlr2ontheproliferationofinflammationrelatedcolorectalcancerandsporadiccolorectalcancer
AT yingjieli effectoftlr2ontheproliferationofinflammationrelatedcolorectalcancerandsporadiccolorectalcancer
AT xiaozhenzang effectoftlr2ontheproliferationofinflammationrelatedcolorectalcancerandsporadiccolorectalcancer
AT zhengjiang effectoftlr2ontheproliferationofinflammationrelatedcolorectalcancerandsporadiccolorectalcancer
AT huahanning effectoftlr2ontheproliferationofinflammationrelatedcolorectalcancerandsporadiccolorectalcancer
AT jingli effectoftlr2ontheproliferationofinflammationrelatedcolorectalcancerandsporadiccolorectalcancer